BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22490695)

  • 1. [Diagnostic value of soluble B7-H4 in malignant pleural effusion].
    Xu CH; Yu LK
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):117-8. PubMed ID: 22490695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
    Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
    Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C; Qian L; Yu L; Zhang X; Wang Q
    Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of C-C chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of soluble H7-B4 in pleural effusion associated with lung cancer.
    Xu CH; Cao L; Zhang XW; Yan J; Yu LK
    Tumour Biol; 2015 Jun; 36(6):4397-403. PubMed ID: 25636447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
    Tian RX; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
    Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP; Hu CP; Yang HZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early secretory antigenic target protein-6/culture filtrate protein-10 fusion protein-specific Th1 and Th2 response and its diagnostic value in tuberculous pleural effusion].
    Ge QP; He ZY; Gao WW; DU FJ; Wei PJ; Jia HY; Ma Y; Zhang ZD
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):406-10. PubMed ID: 24103202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy].
    Krenke R; Safianowska A; Paplińska M; Korczyński P; Dmowska-Sobstyl B; Bogacka-Zatorska E; Jaworski A; Chazan R
    Pneumonol Alergol Pol; 2008; 76(4):237-45. PubMed ID: 18785128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions.
    Porcel JM; Vives M; Gázquez I; Vicente de Vera MC; Pérez B; Rubio M
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):76-82. PubMed ID: 10654648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase activity level as a tool for diagnosing tuberculous pleural effusion.
    Khow-Ean N; Booraphun S; Aekphachaisawat N; Sawanyawisuth K
    Southeast Asian J Trop Med Public Health; 2013 Jul; 44(4):655-9. PubMed ID: 24050100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of cholesterol in pleural effusions.
    Ram KN; Sing RS
    J Assoc Physicians India; 1995 Nov; 43(11):748-50. PubMed ID: 8773031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
    Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy.
    Kohmo S; Kijima T; Mori M; Minami T; Namba Y; Yano Y; Yoneda T; Takeda Y; Kitada S; Yamaguchi T; Tachibana I; Yokota S
    Tuberculosis (Edinb); 2012 May; 92(3):248-52. PubMed ID: 22297026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.